Thank you for your interest in Traversa Therapeutics. You can contact us using the phone number listed below or fill out the form to email us.
Traversa Therapeutics, Inc.
10480 Wateridge Circle
San Diego, CA 92121-5773
(858) 454-8400
- March 25, 2010 Traversa Therapeutics and sanofi-aventis enter into a research agreement for the development of Traversa's RNAi delivery technology
- January 6, 2010 Traversa Appoints Curt W. Bradshaw, Ph.D. as VP of Research & Development
- April 2, 2009 Traversa Therapeutics Completes Series B Financing. Company continues to advance toward the clinic with novel RNA interference technologies.
- March 24, 2009 Traversa Therapeutics announces appointment of William G. Kaelin, Jr., M.D. and Yitzhak Tor, Ph.D. to the company's scientific advisory board
- February 4, 2008 Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing
